AONC American Oncology Network, Inc.: Nilai bisnis marang pendapatan

Logo perusahaan publik AON (AONC)

The enterprise value-to-revenue chart illustrates market expectations for American Oncology Network (AONC), where the value serves as the current metric. AI analytics and medical record automation, which reduce routine tasks, are driving positive sentiment. Outsourcing logistics and IT support to third-party providers is further enhancing efficiency. However, regulatory restrictions on drug spreads and rising compliance costs are exerting pressure on the bottom line.

AONC American Oncology Network, Inc.: Multiplikator EV/Sales ing interval 04.07.2022 - 20.11.2026

AONC (American Oncology Network Inc): rincian analitis lan laporan miturut indikator

- data kapitalisasi saham perusahaan:
- informasi babagan dhuwit lan arus kas:
Pambiji fundamental:AON AONC
Produk seri American Oncology Network, Inc.

It is critical for investors to determine whether they are overpaying for the asset amid yield volatility and specific industry risks. By analyzing the current Enterprise Value to Revenue multiple of American Oncology Network (AONC), you evaluate the business regardless of debt load, which allows for a comparison of market capitalization against the actual sales volume of American Oncology Network (AONC), while accounting for margin pressure driven by drug costs and efforts to stabilize it through IT optimization of pharmacies.

Analisis pesaing

Rasio nilai perusahaan marang dodolan BeiGene Ltd (ONC)|Halozyme Corp (HALO) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Revolution Medicines Inc (RVMD)|Rasio nilai perusahaan marang pendapatan Ascentage Pharma Group|Rasio nilai perusahaan marang pendapatan CGON (CG Oncology Corp)|Rasio nilai perusahaan marang pendapatan UroGen Pharma (URGN)|Multiplikator EV/Sales Bicara Therapeutics (BCAX)|Multiplikator EV/Sales PSNL (personalis.com)|Nilai bisnis marang pendapatan ERAS|DCTH: Nilai perusahaan marang pendapatan|YmAbs - Koefisien nilai perusahaan marang pendapatan|aurabiosciences.com (AURA) - Rasio nilai perusahaan marang pendapatan|Candel Therapeutics Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Accuray Inc.|Multiplikator nilai perusahaan marang pendapatan SELLAS Life Sciences Group SLS|Multiplikator EV/Sales ACTU|CTOR - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales HURA (TuHURA Biosciences, Inc.)|Nilai bisnis marang pendapatan TARA|FATE: Nilai perusahaan marang pendapatan|WHWK (aadibio.com) - Rasio nilai perusahaan marang pendapatan|TCRX (TScan Therapeutics, Inc.) - Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Multiplikator EV/Sales|CVM (CEL-SCI Corporation) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales OSTX|Multiplikator EV/Sales Radiopharm Theranostics Ltd (RADX)|Multiplikator EV/Sales ARTV (Artiva Biotherapeutics)|Multiplikator EV/Sales Adlai Nortye Ltd. ANL|Veru Inc - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Tempest Therapeutics TPST|XLO: Multiplikator EV/Sales|Enochian BioSciences (RENB) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan MURA|Kairos Pharma Ltd - Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales OKUR|CytoMed Therapeutics Limited (GDTC) - Rasio nilai perusahaan marang dodolan|Multiplikator EV/Sales CRIS (Curis, Inc.)|APLM: Rasio nilai perusahaan marang pendapatan|Tharimmune Corporation - Multiplikator EV/Sales|ADVB: Rasio nilai perusahaan marang pendapatan|GNPX: Multiplikator EV/Sales|CLDI (Calidi Biotherapeutics Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Sunshine Biopharma, Inc.|Multiplikator EV/Sales xeneticbio.com|Rasio nilai perusahaan marang pendapatan Salarius (SLRX)|Nilai perusahaan marang pendapatan Purple Biotech PPBT|Multiplikator EV/Sales BGNE (BeiGene Ltd.)|Koefisien nilai perusahaan marang pendapatan CKPT (Checkpoint Therapeutics)|ELEV - Rasio nilai perusahaan marang pendapatan|ICAD (iCAD Inc.) - Rasio nilai perusahaan marang pendapatan|Ikena (IKNA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Notable Labs, Ltd.|Rasio nilai perusahaan marang pendapatan viracta.com|MOR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales NAYA|Ascentage Pharma - Rasio nilai perusahaan marang pendapatan